2025 Trends in Pharmaceutical Contract Manufacturing:
Where Sustainability Meets Disruption The pharmaceutical contract manufacturing companies (CDMO) is no longer simply adapting to change it is driving the transformation of global pharma. As we move toward a market projected to reach $320 billion by 2029, CDMOs stand at the forefront of a paradigm shift where technological innovation and sustainability are no longer parallel tracks,…